<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23814" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Job Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafsi</surname>
            <given-names>Wissem</given-names>
          </name>
          <aff>Faculty of Medicine of Tunis, Tunisia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Wissem Hafsi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23814.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Job Syndrome (Hyper-IgE syndrome) is a rare, primary immunodeficiency distinguished by the clinical triad of atopic dermatitis, recurrent skin staphylococcal infections, and recurrent pulmonary infections. The disease is characterized by elevated IgE levels with an early onset in primary childhood. This activity reviews the evaluation and management of Job syndrome and highlights the role of the interprofessional team in educating patients about their prognosis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the differential diagnosis of Job syndrome.</p></list-item><list-item><p>Outline the risk factors of developing Job syndrome.</p></list-item><list-item><p>Describe the pathophysiology of Job syndrome.</p></list-item><list-item><p>Summarize the interprofessional team's strategies for improving care coordination and communication regarding the management of patients with Job syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23814&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23814">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23814.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hyper-IgE syndrome (HIES) is a rare, primary immunodeficiency distinguished by the clinical triad of atopic dermatitis, recurrent skin staphylococcal infections,&#x000a0;and recurrent pulmonary infections. Furthermore, there are elevated IgE levels of early-onset in primary childhood.</p>
        <p>David&#x000a0;et al. first described reported&#x000a0;"Job syndrome"&#x000a0;in 1966 in two patients with eczema, recurrent pulmonary infections, and cold lung abscesses. Later, in 1972, Buckley et al. reported the association of this condition with increased serum immunoglobulin E (hyper-IgE) levels and a series of phenotypic features called HIES.</p>
        <p>The HIES is classified into 2 types.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Type I: Autosomal dominant&#x000a0;hyper-IgE syndrome&#x000a0;(AD-HIES), in which patients have abnormalities in different systems, including the immune system, connective tissue, skeletal and vascular among others</p>
          </list-item>
          <list-item>
            <p>Type II: Autosomal recessive&#x000a0;hyper-IgE syndrome&#x000a0;(AR-HIES), which also affects the immune system, manifesting in high IgE, recurrent skin and lung infections, sensitivity to viral infections such as molluscum contagiosum, and central nervous system (CNS) involvement, but does not have musculoskeletal alterations</p>
          </list-item>
        </list>
        <p>Most recently, the International Union of Immunology Societies describes primary immunodeficiencies (PID) with well-defined syndromes as AD-HIES (Job syndrome) and&#x000a0;3 subtypes of AR-HIES that do not present skeletal or pneumatoceles alterations. These are further subdivided into TYK2 deficiency, DOCK8 deficiency, according to a molecular abnormality, and one of unknown origin.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r2">[2]</xref><xref ref-type="bibr" rid="article-23814.r3">[3]</xref></p>
      </sec>
      <sec id="article-23814.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Job syndrome&#x000a0;is due to a mutation in the&#x000a0;<italic toggle="yes">STAT3</italic>&#x000a0;gene in more than two-thirds of cases (70%). The transmission of this syndrome is autosomal dominant and variable expressivity. More than 90 different mutations have been reported. In the rest of the cases, the etiology of&#x000a0;Job syndrome&#x000a0;remains unclear.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r4">[4]</xref></p>
      </sec>
      <sec id="article-23814.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The annual incidence of Job syndrome&#x000a0;is estimated at around 1: 1,000,000. Although initially described in female subjects, both genders are affected, with no ethnic factor.&#x000a0;A family character has only rarely been described.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref></p>
      </sec>
      <sec id="article-23814.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Job syndrome is due to a specific genetic mutation of autosomal dominant inheritance in the <italic toggle="yes">STAT3</italic>. <italic toggle="yes">STAT3</italic>&#x000a0;is involved in healing mechanisms and immune mechanisms. The mutation of this gene will lead to an intensification of the production of immunoglobulin E by B lymphocytes, the loss of the modulation capacity of their production by IL-6, IL-10, and IFN-gamma, and a defect chemotaxis of neutrophils. The lack of anti-inflammatory effects of IL-10 is probably the cause of the inappropriate inflammatory response observed in patients with Job syndrome. IL-6 plays an essential role in the genesis of Th17 cells; therefore, the lack of this cytokine leads to a deficiency of Th17 cells in Job syndrome. The CD4 + Th17 cells play an important role in the defense against infections mainly bacteria and extracellular fungi.</p>
        <p>In addition, aside from its immunological role, this molecule has the role of pleiotropic signaling, which explains other non-immunological findings observed in the Job syndrome, such as long bone fractures and a late rash. Secondary teeth with primary teeth retained among immunodeficiencies.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r4">[4]</xref></p>
      </sec>
      <sec id="article-23814.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Job syndrome is characterized by clinical signs of immunological and non-immunological order.</p>
        <p>
<bold>Immunological Features</bold>
</p>
        <p>These mainly include chronic eczematoid eruptions, recurrent skin and pulmonary bacterial infections, and mucocutaneous candidiasis. The skin manifestations usually appear very early, a few weeks after birth. They include a pruriginous eczematoid rash affecting the scalp and face, that is rapidly superinfected with <italic toggle="yes">Staphylococcus aureus</italic>, resulting in weeping, crusty, and follicular infectious lesions. Recurrent cold staphylococcal skin abscesses that are associated with little or no inflammation are seen in these patients. <italic toggle="yes">Candida</italic> infections are common; they affect the skin, mucous membranes, and nails.</p>
        <p>Recurrent pneumonia is typical, predominately due to <italic toggle="yes">S. aureus</italic>, and less frequently due to&#x000a0;<italic toggle="yes">Streptococcus pneumoniae, and&#x000a0;</italic><italic toggle="yes">Haemophilus.</italic>&#x000a0;It can get complicated with the development of recurrent lung abscesses, bronchiectasis, and pneumatoceles. These pneumatoceles can get colonized with&#x000a0;<italic toggle="yes">Aspergillus </italic>and<italic toggle="yes"> Pseudomonas</italic>. Superinfection with Pneumocystis carinii<xref ref-type="bibr" rid="article-23814.r5">[5]</xref> was also reported.</p>
        <p>Cryptococcosis and histoplasmosis can manifest outside the lung. Other infectious manifestations such as sinusitis, bronchitis, otitis externa, gingivitis, dental abscess, septic arthritis, and osteomyelitis&#x000a0;can be seen.<xref ref-type="bibr" rid="article-23814.r6">[6]</xref><xref ref-type="bibr" rid="article-23814.r7">[7]</xref><xref ref-type="bibr" rid="article-23814.r8">[8]</xref><xref ref-type="bibr" rid="article-23814.r9">[9]</xref><xref ref-type="bibr" rid="article-23814.r10">[10]</xref><xref ref-type="bibr" rid="article-23814.r11">[11]</xref><xref ref-type="bibr" rid="article-23814.r12">[12]</xref><xref ref-type="bibr" rid="article-23814.r13">[13]</xref><xref ref-type="bibr" rid="article-23814.r14">[14]</xref><xref ref-type="bibr" rid="article-23814.r15">[15]</xref><xref ref-type="bibr" rid="article-23814.r16">[16]</xref><xref ref-type="bibr" rid="article-23814.r17">[17]</xref><xref ref-type="bibr" rid="article-23814.r18">[18]</xref><xref ref-type="bibr" rid="article-23814.r17">[17]</xref><xref ref-type="bibr" rid="article-23814.r16">[16]</xref><xref ref-type="bibr" rid="article-23814.r14">[14]</xref><xref ref-type="bibr" rid="article-23814.r19">[19]</xref><xref ref-type="bibr" rid="article-23814.r14">[14]</xref></p>
        <p>
<bold>Non-immunological Features</bold>
</p>
        <p>Patients with Job syndrome&#x000a0;have characteristic facial features that appear in early adolescence or earlier in late childhood, for example, facial asymmetry, prominent forehead, deep-set eyes, broad nasal bridge,&#x000a0;wide fleshy nasal tip<xref ref-type="bibr" rid="article-23814.r20">[20]</xref>, rough fascial skin, increased inter-alar distance, prognathism, and high-arched palate. Birth defects like craniosynostosis and Arnold Chiari type 1 malformation have been documented.</p>
        <p>Musculoskeletal abnormalities are common. They include hyperextensibility of the joints, scoliosis, and osteopenia. Hyperextensibility(noted in about 68% of the patients) may result in the early onset of degenerative joints disease. Bone density is decreased and is the source of multiple pathological fractures that occur in approximately 50% of patients (long bones and ribs). Scoliosis of variable severity is observed in approximately 60% of patients.</p>
        <p>Anomalies of dentinogenesis are possible&#x000a0;manifestations. Decreased resorption of the roots of the deciduous teeth may result in prolonged retention of the deciduous teeth, preventing the appearance of definitive teeth. About 70% of the patients with Job syndrome have been reported to retain three or more primary teeth.</p>
        <p>Vascular manifestations include tortuosity or dilatation, coronary, cerebral and aortic aneurysms, and congenital coronary artery abnormalities.</p>
        <p>Ocular complications include xanthelasmas, chalazions, strabismus and retinal detachment.<xref ref-type="bibr" rid="article-23814.r6">[6]</xref><xref ref-type="bibr" rid="article-23814.r7">[7]</xref><xref ref-type="bibr" rid="article-23814.r8">[8]</xref><xref ref-type="bibr" rid="article-23814.r9">[9]</xref><xref ref-type="bibr" rid="article-23814.r10">[10]</xref><xref ref-type="bibr" rid="article-23814.r11">[11]</xref><xref ref-type="bibr" rid="article-23814.r12">[12]</xref><xref ref-type="bibr" rid="article-23814.r13">[13]</xref><xref ref-type="bibr" rid="article-23814.r14">[14]</xref><xref ref-type="bibr" rid="article-23814.r15">[15]</xref><xref ref-type="bibr" rid="article-23814.r21">[21]</xref><xref ref-type="bibr" rid="article-23814.r15">[15]</xref><xref ref-type="bibr" rid="article-23814.r14">[14]</xref><xref ref-type="bibr" rid="article-23814.r19">[19]</xref><xref ref-type="bibr" rid="article-23814.r14">[14]</xref></p>
      </sec>
      <sec id="article-23814.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The main diagnostic feature is an increase in serum IgE levels of more than 2000 U/mL, and often 500 U/mL. A clinical score has been developed to define the probability of diagnosis. A total IgE concentration greater than 1000 IU/mL and a weighted score of greater than 30 indicate an AD-HIES of the defect in <italic toggle="yes">STAT3</italic>, and a dominant-negative heterozygote mutation in <italic toggle="yes">STAT3</italic> confirms the diagnosis.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r6">[6]</xref></p>
        <p>Eosinophilia is observed in more than 90% of the patients. The WBC count can be normal, elevated, or reduced in number(neutropenia).<xref ref-type="bibr" rid="article-23814.r15">[15]</xref></p>
      </sec>
      <sec id="article-23814.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The most effective treatment, for now, for this condition is the long-term, sometimes continuous, use of antibiotics (penicillinase-resistant penicillins, cephalosporins, antifungal agents, and others) by adapting the treatment to the infections occurring in these patients and sometimes using surgical procedures during abscess development.</p>
        <p>Interferon-gamma has shown no clinical benefit in this condition. Thanks to the antibiotics, and if the diagnosis is made early, patient survival can be increased. The management of non-immunological manifestations must be interprofessional. It aims to treat complications. Thus, scoliosis,&#x000a0;depending on its severity,&#x000a0;as well as bone fractures and degenerative joints diseases&#x000a0;may require orthopedic surgery. Dental abnormalities require adequate stomatological treatment. Cardiovascular complications are managed in a specialized environment.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r6">[6]</xref><xref ref-type="bibr" rid="article-23814.r7">[7]</xref><xref ref-type="bibr" rid="article-23814.r9">[9]</xref></p>
        <p>Bone-marrow transplantation has been associated with mixed results in these patients.<xref ref-type="bibr" rid="article-23814.r15">[15]</xref></p>
      </sec>
      <sec id="article-23814.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>According to the clinical presentation, the diagnosis of Job syndrome&#x000a0;could be difficult and arise with other diagnoses including in particular&#x000a0;other types of primitive (chronic granulomatous disease) or acquired (HIV infection) immunodeficiency, severe atopic dermatitis, or cystic fibrosis.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r11">[11]</xref></p>
      </sec>
      <sec id="article-23814.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although AD-HIES is associated with high morbidity and mortality, advances in medical care, close monitoring and patient compliance have led to improved prognosis, with survival up to 50 years or more.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r22">[22]</xref></p>
      </sec>
      <sec id="article-23814.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Malignancies especially non-Hodgkin's lymphoma. Other cancers have also been reported such as Hodgkin's lymphoma, cancers of the vulva, and the lung.</p>
          </list-item>
          <list-item>
            <p>Autoimmune diseases like SLE, membranoproliferative glomerulonephritis, vasculitis, and dermatomyositis.</p>
          </list-item>
          <list-item>
            <p>Hypertension&#x000a0;associated with vascular abnormalities.</p>
          </list-item>
          <list-item>
            <p>Myocardial infarction due to the rupture of coronary aneurysms.</p>
          </list-item>
          <list-item>
            <p>Lacunar infarcts due to the rupture of cerebral aneurysms.<xref ref-type="bibr" rid="article-23814.r15">[15]</xref><xref ref-type="bibr" rid="article-23814.r19">[19]</xref><xref ref-type="bibr" rid="article-23814.r15">[15]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23814.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Job syndrome is a rare, primary immunodeficiency due to mutations in <italic toggle="yes">STAT3</italic> and characterized by defects in immunity with eczematous and non-immunologic system disorders. Antenatal diagnosis is theoretically possible. However, the very low incidence and the sporadic nature in the majority of cases make this method without much interest. The treatment at the moment is purely symptomatic. A biological or gene therapy in the future&#x000a0;could change the prognosis of this syndrome.</p>
      </sec>
      <sec id="article-23814.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Job syndrome is a rare immunological disorder characterized by recurrent infections. The disorder is primarily managed by the hematologist and infectious disease expert but the outpatient&#x000a0;follow-up is done by the primary caregiver and nurse practitioner as part of interprofessional team management. Most of these patients require long term antibiotic therapy combined with drainage of an abscess, so a pharmaceutical consult is in order to appropriately target antimicrobial therapy.</p>
        <p>The management of non-immunological manifestations must be interprofessional. It aims to treat complications. Thus, scoliosis,&#x000a0;depending on its severity,&#x000a0;as well as bone fractures and degenerative joints diseases&#x000a0;may require orthopedic surgery. Dental abnormalities require adequate stomatological treatment. Cardiovascular complications are managed in a specialized environment.<xref ref-type="bibr" rid="article-23814.r1">[1]</xref><xref ref-type="bibr" rid="article-23814.r6">[6]</xref><xref ref-type="bibr" rid="article-23814.r7">[7]</xref><xref ref-type="bibr" rid="article-23814.r9">[9]</xref>&#x000a0;An outpatient nurse should make regular home visits to ensure that the patient's health is stable, and report back to the healthcare team regarding their findings. These interprofessional activities can improve patient care significantly. [Level 5] While the outlook has improved with better care over the past 3 decades, many of these patients do have a shortened life span.</p>
      </sec>
      <sec id="article-23814.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23814&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23814">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/job-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23814">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23814/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23814">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23814.s15">
        <title>References</title>
        <ref id="article-23814.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>XP</given-names>
              </name>
            </person-group>
            <article-title>[Hyper-IgE syndromes].</article-title>
            <source>Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</source>
            <year>2017</year>
            <month>Jun</month>
            <day>05</day>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>892</fpage>
            <page-range>892-896</page-range>
            <pub-id pub-id-type="pmid">29775011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponsford</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Klocperk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pulvirenti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dalm</surname>
                <given-names>VASH</given-names>
              </name>
              <name>
                <surname>Milota</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cinetto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chovancova</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Rial</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Sediva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Litzman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>van Hagen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jolles</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hyper-IgE in the allergy clinic--when is it primary immunodeficiency?</article-title>
            <source>Allergy</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>73</volume>
            <issue>11</issue>
            <fpage>2122</fpage>
            <page-range>2122-2136</page-range>
            <pub-id pub-id-type="pmid">30043993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gernez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Garabedian</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Akhter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Secord</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ochs</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Fuleihan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Routes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Muskat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lugar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2018</year>
            <season>May-Jun</season>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>996</fpage>
            <page-range>996-1001</page-range>
            <pub-id pub-id-type="pmid">28939137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sahu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Minz</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Rawat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saikia</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1080</fpage>
            <pub-id pub-id-type="pmid">29868029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gallin</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Malech</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Mar</month>
            <day>04</day>
            <volume>340</volume>
            <issue>9</issue>
            <fpage>692</fpage>
            <page-range>692-702</page-range>
            <pub-id pub-id-type="pmid">10053178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santana</surname>
                <given-names>PRP</given-names>
              </name>
              <name>
                <surname>Medeiros</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Barbisan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>ACP</given-names>
              </name>
              <name>
                <surname>Marchiori</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hyperimmunoglobulin E syndrome (Job syndrome): chest CT findings.</article-title>
            <source>J Bras Pneumol</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>335</fpage>
            <page-range>335-336</page-range>
            <pub-id pub-id-type="pmid">30020346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pe&#x000f1;a-L&#x000f3;pez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Monteagudo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Jorge</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Fern&#x000e1;ndez</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>[Cutaneous manifestations in an infant with hyper-IgE syndrome].</article-title>
            <source>An Pediatr (Engl Ed)</source>
            <year>2019</year>
            <month>May</month>
            <volume>90</volume>
            <issue>5</issue>
            <fpage>319</fpage>
            <page-range>319-320</page-range>
            <pub-id pub-id-type="pmid">29703558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pediatric hyperimmunoglobulin E syndrome: A case series of 4 children in China.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>97</volume>
            <issue>14</issue>
            <fpage>e0215</fpage>
            <pub-id pub-id-type="pmid">29620631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jagia</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Artery Pseudoaneurysm in Hyper-IgE Syndrome: Rare Complication With Successful Endovascular Management.</article-title>
            <source>Vasc Endovascular Surg</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>375</fpage>
            <page-range>375-377</page-range>
            <pub-id pub-id-type="pmid">29552943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Qurie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Immunodeficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29763203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hagl</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>[Atopic eczema in childhood or primary immunodeficiency - what needs to be considered?].</article-title>
            <source>MMW Fortschr Med</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>159</volume>
            <issue>20</issue>
            <fpage>59</fpage>
            <page-range>59-63</page-range>
            <pub-id pub-id-type="pmid">29159616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devilliers</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Turcu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vernier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bielefeld</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonniaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Besancenot</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>[Hyper-IgE in internal medicine].</article-title>
            <source>Rev Med Interne</source>
            <year>2018</year>
            <month>May</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>332</fpage>
            <page-range>332-338</page-range>
            <pub-id pub-id-type="pmid">29397233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geeta Mg</surname>
              </name>
              <name>
                <surname>Riyaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scaria</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Rapid Transition of Facial Features from Early to Mid - Adolescence in Autosomal Dominant Hyper IgE Syndrome with a STAT3 Variation.</article-title>
            <source>Indian J Pediatr</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>85</volume>
            <issue>7</issue>
            <fpage>595</fpage>
            <page-range>595-596</page-range>
            <pub-id pub-id-type="pmid">29368105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knoedler</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Minutillo</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Knee Pain in a Boy With Hyper IgE Type 1 Syndrome (Job Variant).</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>9</issue>
            <fpage>882</fpage>
            <page-range>882-884</page-range>
            <pub-id pub-id-type="pmid">28720031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yong</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Engelhardt</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>An update on the hyper-IgE syndromes.</article-title>
            <source>Arthritis Res Ther</source>
            <year>2012</year>
            <month>Nov</month>
            <day>30</day>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>228</fpage>
            <pub-id pub-id-type="pmid">23210525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lui</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Inculet</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Job's syndrome: a rare cause of recurrent lung abscess in childhood.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>992</fpage>
            <page-range>992-4</page-range>
            <pub-id pub-id-type="pmid">2241394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shamberger</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Wohl</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Perez-Atayde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hendren</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Pneumatocele complicating hyperimmunoglobulin E syndrome (Job's Syndrome).</article-title>
            <source>Ann Thorac Surg</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>54</volume>
            <issue>6</issue>
            <fpage>1206</fpage>
            <page-range>1206-8</page-range>
            <pub-id pub-id-type="pmid">1449312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000f6;r&#x000fc;r</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ozcan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Unal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akba&#x0015f;</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vayiso&#x0011f;lu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Hyper immunoglobulin-E syndrome: a case with chronic ear draining mimicking polypoid otitis media.</article-title>
            <source>Int J Pediatr Otorhinolaryngol</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-12</page-range>
            <pub-id pub-id-type="pmid">12663115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szczawinska-Poplonyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kycler</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Pietrucha</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heropolitanska-Pliszka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Breborowicz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gerreth</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2011</year>
            <month>Nov</month>
            <day>15</day>
            <volume>6</volume>
            <fpage>76</fpage>
            <pub-id pub-id-type="pmid">22085750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hashemi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mohebbi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mehravaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mazloumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jahanbani-Ardakani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abtahi</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.</article-title>
            <source>J Res Med Sci</source>
            <year>2017</year>
            <volume>22</volume>
            <fpage>53</fpage>
            <pub-id pub-id-type="pmid">28567072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freeman</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Avila</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Matta</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hadigan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pettigrew</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gharib</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery abnormalities in Hyper-IgE syndrome.</article-title>
            <source>J Clin Immunol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>338</fpage>
            <page-range>338-45</page-range>
            <pub-id pub-id-type="pmid">21494893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23814.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazregari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tavakol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asgardoon</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kiaee</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tavakolinia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Valizadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency.</article-title>
            <source>Cent Eur J Immunol</source>
            <year>2017</year>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>336</fpage>
            <page-range>336-341</page-range>
            <pub-id pub-id-type="pmid">29479289</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
